Detailed information for compound 985920

Basic information

Technical information
  • TDR Targets ID: 985920
  • Name: [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxy methyl)oxan-2-yl] 4-[(2S,3R,4S,5S,6R)-3,4,5-t rihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzo ate
  • MW: 462.402 | Formula: C19H26O13
  • H donors: 8 H acceptors: 9 LogP: -2.52 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC[C@H]1O[C@@H](Oc2ccc(cc2)C(=O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
  • InChi: 1S/C19H26O13/c20-5-9-11(22)13(24)15(26)18(30-9)29-8-3-1-7(2-4-8)17(28)32-19-16(27)14(25)12(23)10(6-21)31-19/h1-4,9-16,18-27H,5-6H2/t9-,10-,11-,12-,13+,14+,15-,16-,18-,19+/m1/s1
  • InChiKey: MMVLVHFEKMGNDI-XXQLXNJGSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxybenzoate
  • 4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]benzoic acid [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl] ester
  • 4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxybenzoic acid [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl] ester

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Toxoplasma gondii eukaryotic initiation factor-4A, putative 0.0274 0.2925 1
Entamoeba histolytica DEAD/DEAH box helicase, putative 0.0274 0.2925 1
Echinococcus granulosus eukaryotic initiation factor 4A III 0.0274 0.2925 1
Echinococcus multilocularis ribonucleoside diphosphate reductase large 0.021 0.2003 0.6777
Loa Loa (eye worm) hypothetical protein 0.0274 0.2925 0.288
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Plasmodium falciparum ribonucleoside-diphosphate reductase large subunit, putative 0.021 0.2003 0.6777
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Mycobacterium tuberculosis Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) 0.0274 0.2925 1
Wolbachia endosymbiont of Brugia malayi ribonucleotide-diphosphate reductase subunit alpha 0.0195 0.1782 0.5
Treponema pallidum ATP-dependent RNA helicase 0.0274 0.2925 1
Mycobacterium leprae RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE (ALPHA CHAIN) NRDE (RIBONUCLEOTIDE REDUCTASE SMALL SUBUNIT) (R1F PROTEIN) 0.0195 0.1782 0.5
Trypanosoma brucei ribonucleoside-diphosphate reductase large chain 0.021 0.2003 0.6777
Chlamydia trachomatis ribonucleoside-diphosphate reductase subunit alpha 0.021 0.2003 0.5
Mycobacterium tuberculosis Ribonucleoside-diphosphate reductase (alpha chain) NrdE (ribonucleotide reductase small subunit) (R1F protein) 0.0195 0.1782 0.609
Leishmania major eukaryotic initiation factor 4a, putative 0.0274 0.2925 1
Toxoplasma gondii ribonucleoside-diphosphate reductase large chain 0.021 0.2003 0.6777
Schistosoma mansoni ribonucleoside-diphosphate reductase alpha subunit 0.021 0.2003 0.1952
Giardia lamblia Translation initiation factor eIF-4A, putative 0.0274 0.2925 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Leishmania major ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.0769 1 1
Trypanosoma cruzi ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777
Plasmodium vivax RNA helicase-1, putative 0.0274 0.2925 1
Echinococcus multilocularis eukaryotic initiation factor 4A III 0.0274 0.2925 1
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0274 0.2925 0.288
Schistosoma mansoni serine/threonine protein kinase 0.0769 1 1
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0274 0.2925 0.288
Plasmodium falciparum eukaryotic initiation factor 4A 0.0274 0.2925 1
Echinococcus granulosus eukaryotic initiation factor 4A 0.0274 0.2925 1
Trichomonas vaginalis ribonucleoside-diphosphate reductase alpha chain, putative 0.0195 0.1782 0.6002
Leishmania major eukaryotic initiation factor 4a, putative 0.0274 0.2925 1
Brugia malayi eukaryotic initiation factor 4A 0.0274 0.2925 0.288
Echinococcus granulosus ribonucleoside diphosphate reductase large 0.021 0.2003 0.6777
Brugia malayi ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.1952
Loa Loa (eye worm) ribonucleoside-diphosphate reductase large subunit 0.021 0.2003 0.1952
Mycobacterium ulcerans ribonucleotide-diphosphate reductase subunit alpha 0.0195 0.1782 0.5
Trypanosoma brucei Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Plasmodium vivax ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777
Echinococcus multilocularis eukaryotic initiation factor 4A 0.0274 0.2925 1
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Onchocerca volvulus Eukaryotic initiation factor 4A homolog 0.0274 0.2925 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.